H.R.4784: Lower Drug Costs through Competition Act

About This Bill

Bill Summary

Lower Drug Costs through Competition Act This bill amends the Federal Food, Drug, and Cosmetic Act to revise provisions regarding review and approval of generic drug applications or supplements to generic drug applications for drugs: (1) for which there is a shortage, or (2) that have not been recently introduced to the market by more than one manufacturer and for which tentative approval has not been granted to more than two applications. The...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There are 2 statements associated with H.R.4784.

Bill Actions

Date Description
March 18, 2016
Referred to the Subcommittee on Health.
March 17, 2016
Referred to the House Committee on Energy and Commerce.
March 17, 2016

Introduced in the House by Kurt Schrader (D-Ore.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page